Cargando…

IMRT Reduces Acute Toxicity in Patients Treated With Preoperative Chemoradiation for Gastric Cancer

PURPOSE: Preoperative chemoradiation is being currently evaluated in 2 randomized international trials. However, chemoradiation for gastric cancer can be associated with relatively high rates of acute toxicity. We compared rates of toxicity, toxicity-related events, and oncologic outcomes in patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moningi, Shalini, Ajani, Jaffer A., Badgwell, Brian D., Murphy, Mariela B., Ikoma, Naruhiko, Mansfield, Paul F., Ho, Jennifer C., Suh, Yelin, Crane, Christopher, Herman, Joseph M., Holliday, Emma B., Koay, Eugene, Koong, Albert C., Krishnan, Sunil, Minsky, Bruce, Smith, Grace, Taniguchi, Cullen, Das, Prajnan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Gastrointestinal Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276694/ https://www.ncbi.nlm.nih.gov/pubmed/32529130 http://dx.doi.org/10.1016/j.adro.2019.11.003

Ejemplares similares

Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma: Outcomes and Toxicity of 428 Patients Treated at a Single Institution
por: Holliday, Emma B, et al.
Publicado: (2022)

Independent Stage Classification for Gastroesophageal Junction Adenocarcinoma
por: Hirata, Yuki, et al.
Publicado: (2023)

Preoperative Therapy Regimen Influences the Incidence and Implication of Nodal Downstaging in Patients with Gastric Cancer
por: Stark, Alexander P., et al.
Publicado: (2020)

Staging laparoscopy and peritoneal cytology in patients with early stage gastric adenocarcinoma
por: Allen, Casey J., et al.
Publicado: (2020)

Patient-Reported Outcomes After Chemoradiation in Patients With Anal Cancer: A Qualitative Analysis
por: Corrigan, Kelsey L., et al.
Publicado: (2022)

Treatment Patterns for Gastroesophageal Junction Adenocarcinoma in the United States †
por: Kim, Bradford J., et al.
Publicado: (2020)

Treatment of primary rectal adenocarcinoma after prior pelvic radiation: The role of hyperfractionated accelerated reirradiation
por: Jensen, Garrett, et al.
Publicado: (2018)

Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis
por: Dodoo, Grace N, et al.
Publicado: (2023)

Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancer
por: Moningi, Shalini, et al.
Publicado: (2022)

Definitive hyperfractionated, accelerated proton reirradiation for patients with pelvic malignancies
por: Moningi, Shalini, et al.
Publicado: (2019)

Treatment of localized gastric and gastroesophageal adenocarcinoma: the role of accurate staging and preoperative therapy
por: Badgwell, Brian, et al.
Publicado: (2017)

Dose escalation with an IMRT technique in 15 to 28 fractions is better tolerated than standard doses of 3DCRT for LAPC
por: Colbert, Lauren E., et al.
Publicado: (2017)

Assessment of setup uncertainty in hypofractionated liver radiation therapy with a breath-hold technique using automatic image registration–based image guidance
por: Choi, Gye Won, et al.
Publicado: (2019)

Hyperfractionated abdominal reirradiation for gastrointestinal malignancies
por: Hunt, Andrew, et al.
Publicado: (2018)

Dose escalation for locally advanced pancreatic cancer: How high can we go?
por: Colbert, Lauren E., et al.
Publicado: (2018)

Mass Transport Model of Radiation Response: Calibration and Application to Chemoradiation for Pancreatic Cancer
por: Wang, Charles X., et al.
Publicado: (2022)

Survival After Induction Chemotherapy and Chemoradiation Versus Chemoradiation and Adjuvant Chemotherapy for Locally Advanced Rectal Cancer
por: Kim, Jin K, et al.
Publicado: (2022)

The role of bone marrow and spleen irradiation in the development of acute hematologic toxicity during chemoradiation for esophageal cancer
por: Chin, Alexander L., et al.
Publicado: (2018)

Preoperatively Treated Diffuse-Type Gastric Adenocarcinoma: Glucose vs. Other Energy Sources Substantially Influence Prognosis and Therapy Response
por: Abdelhakeem, Ahmed A., et al.
Publicado: (2021)

Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation
por: Katz, Matthew H. G., et al.
Publicado: (2010)

Differential Spatial Gene and Protein Expression Associated with Recurrence Following Chemoradiation for Localized Anal Squamous Cell Cancer
por: Hernandez, Sharia, et al.
Publicado: (2023)

Trends of Oncological Quality of Robotic Gastrectomy for Gastric Cancer in the United States
por: Hirata, Yuki, et al.
Publicado: (2023)

Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pancreatic Cancer
por: Moningi, Shalini, et al.
Publicado: (2020)

NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience
por: Bagley, Alexander F., et al.
Publicado: (2022)

18F-FDG PET Predicts Hematologic Toxicity in Patients with Locally Advanced Anal Cancer Treated With Chemoradiation
por: David, John M., et al.
Publicado: (2019)

Long-term analysis of 2 prospective studies that incorporate mitomycin C into an adjuvant chemoradiation regimen for pancreatic and periampullary cancers
por: Schunke, Kathryn J., et al.
Publicado: (2017)

Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma
por: Elganainy, Dalia, et al.
Publicado: (2018)

Atypical extensive pancreatic pseudocyst with hemorrhage in a hemodialysis patient
por: Taniguchi, Yoshinori, et al.
Publicado: (2020)

Histological Regression of Squamous Esophageal Carcinoma Assessed by Percentage of Residual Viable Cells after Neoadjuvant Chemoradiation is an Important Prognostic Factor
por: Tong, Daniel King Hung, et al.
Publicado: (2010)

Feasibility of definitive chemoradiation therapy with nedaplatin and 5-fluorouracil in elderly patients with esophageal squamous cell carcinoma: A retrospective study
por: Watanabe, Akinori, et al.
Publicado: (2018)

MRI Assessment of Complete Response to Preoperative Chemoradiation Therapy for Rectal Cancer: 2020 Guide for Practice from the Korean Society of Abdominal Radiology
por: Park, Seong Ho, et al.
Publicado: (2020)

Influence of oral contrast type and volume on patient experience and quality of luminal distension at MR Enterography in Crohn’s disease: an observational study of patients recruited to the METRIC trial
por: Bhatnagar, Gauraang, et al.
Publicado: (2022)

Definitive radiation therapy for hepatocellular carcinoma with portal vein tumor thrombus
por: Holliday, Emma B., et al.
Publicado: (2017)

Evolution of gastric surgery techniques and outcomes
por: Shiozaki, Hironori, et al.
Publicado: (2016)

Utilization of short-course radiation therapy for patients with nonmetastatic rectal adenocarcinoma in the United States
por: Abdel-Rahman, Omar, et al.
Publicado: (2018)

Intensity modulated radiation therapy (IMRT): differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinoma
por: Mok, Henry, et al.
Publicado: (2011)

Diagnostic utility of ultrasonography and computerized tomography in gall bladder perforation: A case report
por: Pun, B., et al.
Publicado: (2020)

Endoscopic Ultrasound-Guided Fiducial Placement for Stereotactic Body Radiation Therapy in Patients with Pancreatic Cancer
por: Cazacu, Irina M., et al.
Publicado: (2023)

Nonmucinous adenocarcinoma of the cecum presenting as appendicitis complicated by hepatic abscess
por: Adair, Luther B., et al.
Publicado: (2019)

Perforated small bowel GIST in an immunocompromised male
por: Dey, Courtney B., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t8l548rpeloblr4kn815sf667l